{"transactions":[{"id":918394,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67621,"kind":"person","name":"To Lucy","position":1,"cik":"0002032049","reported_name":"To Lucy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-02-05T21:35:02.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":2400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of the Issuer's common stock par value $0.0001 per share, pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":2400000,"derivative":{"exercise_price":4.45,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":2400000},"source":{"system":"sec-edgar","filing":"0001193125-26-039508","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000119312526039508/ownership.xml","form_type":"4"}},{"id":1054161,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67621,"kind":"person","name":"To Lucy","position":1,"cik":"0002032049","reported_name":"To Lucy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-08-28T21:10:04.000Z","date":"2025-08-26","kind":"grant","planned":false,"acquired":true,"shares":1200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of the Issuer's common stock par value $0.0001 per share (\"Common Stock\"), pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended (the \"Plan\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The awards are subject to the Company's receipt of stockholder approval to amend the Plan, to increase the number of shares of Common Stock available for issuance thereunder."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares of Common Stock underlying the option vest over a four-year period, vesting 1/4 on March 1, 2026, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter."}],"balance_after":1200000,"derivative":{"exercise_price":2.17,"expiration_date":"2035-08-26","underlying":"Common Stock","underlying_shares":1200000},"source":{"system":"sec-edgar","filing":"0000950170-25-112056","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017025112056/ownership.xml","form_type":"4"}},{"id":1435373,"issuer":{"id":5816,"kind":"organization","name":"SAB Biotherapeutics, Inc.","symbol":"SABS"},"owners":[{"id":67621,"kind":"person","name":"To Lucy","position":1,"cik":"0002032049","reported_name":"To Lucy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-08-13T21:00:06.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over a four-year period, with 1/4 vesting on the one-year anniversary date from the Reporting Person's commencement of service as Chief Financial Officer (August 12, 2025), and the remainder vesting thereafter in equal monthly installments over a three year period."}],"balance_after":125000,"derivative":{"exercise_price":2.35,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000950170-24-096405","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1833214/000095017024096405/ownership.xml","form_type":"4"}}]}